FDA says its authority to implement the TCA is not limited by Loper Bright, but suggests that future guidance documents may be limited.
On August 26, 2024, the US Food and Drug Administration (FDA or the Agency) filed its...more
9/10/2024
/ Administrative Procedure Act ,
Chevron Deference ,
E-Cigarettes ,
Food and Drug Administration (FDA) ,
Government Agencies ,
Life Sciences ,
Loper Bright Enterprises v Raimondo ,
Medical Devices ,
Pharmaceutical Industry ,
Regulatory Authority ,
Statutory Interpretation ,
Tobacco ,
Tobacco Regulations
The act creates faster, more flexible FDA drug and biologic review, new drug and device approval pathways, increases FDA funding, and reduces EHR administrative burdens.
On December 13, 2016, President Obama signed into...more